Prot #EQ-100-02: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Itolizumab in Combination with Corticosteroids for the Initial Treatment of Acute Graft Versus Host Disease

Project: Research project

Project Details

StatusActive
Effective start/end date7/17/24 → 7/17/27

Funding

  • Equillium, Inc. (Prot #EQ-100-02 // Prot #EQ-100-02)
  • Medpace Clinical Research LLC (Prot #EQ-100-02 // Prot #EQ-100-02)